Knockdown of AATs (SLC1A5/ASCT2, SLC7A5/LAT1, and SLC38A2/SNAT2) inhibits the AA uptake, mTOR activation, and proliferation in CRC cells. This evidence concerns the gene SLC38A2 and colorectal carcinoma.